Gold Nanoparticle-Bioconjugated Aminoguanidine Inhibits Glycation Reaction: An In Vivo Study in a Diabetic Animal Model

Table 4

Level of serum AGEs and CML-AGEs as measured by ELISA in diabetic and AG-Gnp-treated groups.

Group	Serum AGE level (μg mL^-1)	Serum CML level (ng mL^-1)
Control
Diabetic
Diabetic+AG (10 mM)
Diabetic+AG-Gnp (0.5 mM kg^-1)
Diabetic+Ag-Gnp; (1.0 mM kg^-1)

AG: aminoguanidine; AG-Gnp: aminoguanidine gold nanoparticle. Values are the of 3 independent calculations.